News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?
Photo taken from ESTRO/LinkedIn
Jul 25, 2024, 23:48

ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?

European Society for Radiotherapy and Oncology shared on LinkedIn:

“Key insights from ESTRO24 on the optimisation of radiation doses for stage III NSCLC in the era of immunotherapy and tyrosine kinase inhibitors. Learn about dose escalation trials, individualised treatment strategies, and the role of biomarkers in the guidance of therapy.”

Read further.
Source: European Society for Radiotherapy and Oncology/LinkedIn

cancer ESTRO24 European SocieTy for Radiotherapy and Oncology NSCLC OncoDaily Oncology
Special Coverage
Blog
Nov 20, 2024, 10:31
Giulio Draetta and Laura Esserman recieved the 2024 American Italian Cancer Foundation Prize for Scientific Excellence in Medicine
Blog
Nov 20, 2024, 10:18
Andrew Lane received the 2024 David M. Livingston Collaboration Award
Positive
Nov 20, 2024, 10:11
AACR Announced Award Recipients for the 2024 San Antonio Breast Cancer Symposium
Blog
Nov 20, 2024, 10:08
Applications for the 2025 Global Health Delivery Intensive (GHDI) program are now open
Insight
Nov 20, 2024, 06:51
Tracey O’Brien: Supporting Cancer Institute NSW at Parliment House
Insight
Nov 20, 2024, 06:49
Applications are still open for the AACR Scholars in Training Award - KidneyCAN
Blog
Nov 20, 2024, 05:38
Under Pressure: Safeguarding the Health of Europe's Oncology Workforce - European Cancer Organisation
Blog
Nov 20, 2024, 04:03
MELIORA Online Policy Debate - addressing gaps in breast cancer prevention and early detection across Europe
Blog
Nov 20, 2024, 01:07
Karen Knudsen: Touring the Milken Center for Advancing the American Dream
Blog
Nov 20, 2024, 01:00
Miguel Bronchud: Can we afford all new cancer treatments?
Insight
Nov 20, 2024, 00:40
Jarushka Naidoo: ‘TrialGPT:' A new chatGPT for clinical trials
Insight
Nov 20, 2024, 00:37
Fumiko Ladd Chino: A cancer focused workshop in DC before the CaregiverNation24 summit